In this review, we sought to study the result of anti-IgE remedy on tissue eosinophil and mast mobile counts, blood eosinophil counts, and their correlation to symptoms and endoscopy scores of patients with EoE

The study protocol (Pinpointing Responders to Xolair (Omalizumab) Making use of Eosinophilic Esophagitis as a Ailment Design, ClinicalTrials.gov Identifier: NCT01040598) was developed, published, edited, and the data have been saved…